Actimed Therapeutics is a startup. 1 investor tracked.
Actimed Therapeutics is a startup based in the United Kingdom. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Actimed Therapeutics is a clinical-stage biopharmaceutical company focused on developing treatments for cachexia and other muscle wasting disorders. Its lead product, S-pindolol benzoate (ACM-001.1), targets multiple pathways that drive cachexia and has generated promising proof of concept Phase II clinical data in cachexia patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.